BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20961355)

  • 1. Alopecia of the scalp after ineffective treatment of Bowen's disease using red light 5-aminolevulinic acid photodynamic therapy: two case reports.
    Letada PR; Uebelhoer NS; Masters R; Satter EK; Shumaker PR
    Dermatol Surg; 2010 Nov; 36(11):1786-9. PubMed ID: 20961355
    [No Abstract]   [Full Text] [Related]  

  • 2. Red light laser photodynamic therapy of Bowen's disease.
    Parlette EC
    J Drugs Dermatol; 2004; 3(6 Suppl):S22-4. PubMed ID: 15624738
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa.
    Souza CS; Felício LB; Bentley MV; Tedesco AC; Ferreira J; Kurachi C; Bagnato VS
    Br J Dermatol; 2005 Sep; 153(3):672-4. PubMed ID: 16120168
    [No Abstract]   [Full Text] [Related]  

  • 4. Subungual Bowen's disease treated by topical aminolevulinic acid-photodynamic therapy.
    Usmani N; Stables GI; Telfer NR; Stringer MR
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S273-6. PubMed ID: 16227107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
    Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
    J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
    Harth Y; Hirshovitz B
    Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
    Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R
    Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
    Morton CA
    Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of Bowen disease to ALA-PDT using a single and a 2-fold illumination scheme.
    de Haas ER; Sterenborg HJ; Neumann HA; Robinson DJ
    Arch Dermatol; 2007 Feb; 143(2):264-5. PubMed ID: 17310011
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid development of squamous cell carcinoma after photodynamic therapy.
    Liang WM; Theng TS; Lim KS; Tan WP
    Dermatol Surg; 2014 May; 40(5):586-8. PubMed ID: 24858258
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective photodynamic therapy of actinic keratoses and Bowen's disease using microneedle perforation.
    Kolde G; Rowe E; Meffert H
    Br J Dermatol; 2013 Feb; 168(2):450-2. PubMed ID: 22804095
    [No Abstract]   [Full Text] [Related]  

  • 12. Warty and clear-cell Bowen's disease successfully treated with photodynamic treatment.
    Sezer E; Yuksek J
    Photodermatol Photoimmunol Photomed; 2010 Feb; 26(1):48-50. PubMed ID: 20070841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminolevulinic acid photodynamic therapy for skin cancers.
    Blume JE; Oseroff AR
    Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy.
    Stables GI; Stringer MR; Robinson DJ; Ash DV
    Br J Dermatol; 1997 Jun; 136(6):957-60. PubMed ID: 9217836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminolevulinic acid photodynamic therapy for bowenoid papulosis.
    Wu YH; Qiao JJ; Bai J; Fang H
    Indian J Dermatol Venereol Leprol; 2015; 81(2):219-20. PubMed ID: 25751357
    [No Abstract]   [Full Text] [Related]  

  • 16. How we treat Bowen's disease with topical photodynamic therapy in Dundee.
    Attili SK; Ibbotson SH
    Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):41-5. PubMed ID: 19447370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options for Bowen's disease.
    Moreno G; Chia AL; Lim A; Shumack S
    Australas J Dermatol; 2007 Feb; 48(1):1-8; quiz 9-10. PubMed ID: 17222293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
    Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
    Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy for subungual Bowen's disease.
    Tan B; Sinclair R; Foley P
    Australas J Dermatol; 2004 Aug; 45(3):172-4. PubMed ID: 15250896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of sequential therapy in digital Bowen's disease with methyl aminolevulinate photodynamic therapy and topical diclofenac 3% in hyaluronan 2.5% gel.
    Gracia-Cazaña T; López MT; Oncins R; Gilaberte Y
    Dermatol Ther; 2015; 28(6):341-3. PubMed ID: 26291609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.